RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. (From Menkes, Textbook of Child Neurology, 5th ed, p850).
View Complete Description Individual Studies |
|
|---|---|
|
|
Authors: Saskia J G Hoefs, Cindy E J Dieteren, Felix Distelmaier, Rolf J R J Janssen, Andrea Epplen, Herman G P Swarts, Marleen Forkink, Richard J Rodenburg, Leo G Nijtmans, Peter H Willems,…
American journal of human genetics 2008 JunAuthors: Manuel Schiff, Manuele Miné, Michèle Brivet, Cécile Marsac, Monique Elmaleh-Bergés, Philippe Evrard, Hélène Ogier de Baulny
Annals of neurology 2006 AprThought leaders and organizations working on research involving Leigh's disease.
conditions: Huntington Disease ; Chorea ; Attention ; Executive Dysfunction
interventions: 20mg qd citalopram or placebo
conditions: Kartagener Syndrome
interventions: none
R&D Director
PatientsLikeMe
No NextBio groups were found for “Leigh's disease”.
Be the first to
start
a group and share your interests with others within the NextBio community.